In 2011H1, operating revenue and net profit of Chongqing Zhifei Biological Products reached RMB312.48 million and RMB97.59 million, declined by 5.5% and 25.6% YoY respectively. The main reason for the decline was sharply reduced lot release of Hib vaccine, which occupied over 60% of the revenue.
...
Welcome to our website. This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com